A Study of THE-630 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
Conditions:   Gastrointestinal Stromal Tumors (GIST);   Neoplasms, Connective Tissue;   Neoplasms, Connective and Soft Tissue;   Neoplasms by Histologic Type;   Neoplasms;   Gastrointestinal Neoplasms;   Digestive System Neoplasm;   Digestive System Disease;   Gastrointestinal Diseas es Intervention:   Drug: THE-630 Sponsor:   Theseus Pharmaceuticals Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 16, 2021 Category: Research Source Type: clinical trials

A Prospective, Randomized, Multicenter, Comparative Study of the Efficacy of Imatinib Resumption Combined With Atezolizumab Versus Imatinib Resumption Alone in Patients With Unresectable Advanced Gastrointestinal Stromal Tumors (GIST) After Failure of Standard Treatments
Conditions:   Unresectable Gastrointestinal Stromal Tumor (GIST);   Locally Advanced Gastrointestinal Stromal Tumor (GIST);   Metastatic Gastrointestinal Stromal Tumor Interventions:   Drug: Atezolizumab 1200 mg;   Drug: Imatinib 400 MG Sponsor:   Centre Leon Berard Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 9, 2021 Category: Research Source Type: clinical trials